These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3488197)

  • 1. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
    Stobberingh EE; van Eck HJ; Houben AW; van Boven CP
    Drugs; 1986; 31 Suppl 3():23-7. PubMed ID: 3488194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-year survey of Branhamella catarrhalis in a general hospital.
    Smith JM; Lockwood BM
    J Hosp Infect; 1986 May; 7(3):277-82. PubMed ID: 2873174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of Branhamella catarrhalis and other commensal Neisseriaceae in clinical sputum specimens in Lagos, Nigeria.
    Obi MC; Animashaun T; Odugbemi T
    Eur J Epidemiol; 1990 Sep; 6(3):323-5. PubMed ID: 2123801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
    Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
    Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.
    Pollard JA; Wallace RJ; Nash DR; Luman JI; Wilson RW
    Drugs; 1986; 31 Suppl 3():103-8. PubMed ID: 3488188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
    Kamme C; Eliasson I; Knutson BK; Vang M
    Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
    Stobberingh EE; Davies BI; van Boven CP
    J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
    Robinson A; Johnson PC; Griffith SB
    Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel beta-lactamase from Branhamella catarrhalis.
    Hoi-Dang AB; Brive-Le Bouguenec C; Barthelemy M; Labia R
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):397-406. PubMed ID: 311606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
    Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A
    Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
    Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
    Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.
    Aitken JM; Thornley PE
    J Clin Microbiol; 1983 Nov; 18(5):1262-3. PubMed ID: 6643672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity.
    Eliasson I; Kamme C
    J Antimicrob Chemother; 1985 Feb; 15(2):139-49. PubMed ID: 3872294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands.
    Davies BI; Maesen FP
    Drugs; 1986; 31 Suppl 3():28-33. PubMed ID: 3488195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.